WO2019093673A3 - 골질환 예방 또는 치료용 약학 조성물 - Google Patents

골질환 예방 또는 치료용 약학 조성물 Download PDF

Info

Publication number
WO2019093673A3
WO2019093673A3 PCT/KR2018/012305 KR2018012305W WO2019093673A3 WO 2019093673 A3 WO2019093673 A3 WO 2019093673A3 KR 2018012305 W KR2018012305 W KR 2018012305W WO 2019093673 A3 WO2019093673 A3 WO 2019093673A3
Authority
WO
WIPO (PCT)
Prior art keywords
preventing
pharmaceutical composition
bone disease
treating bone
bone
Prior art date
Application number
PCT/KR2018/012305
Other languages
English (en)
French (fr)
Other versions
WO2019093673A2 (ko
Inventor
김정렬
장규윤
박시형
강미애
Original Assignee
전북대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 전북대학교 산학협력단 filed Critical 전북대학교 산학협력단
Publication of WO2019093673A2 publication Critical patent/WO2019093673A2/ko
Publication of WO2019093673A3 publication Critical patent/WO2019093673A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 골질환 예방 또는 치료용 약학 조성물에 관한 것으로, 구체적으로 골다공증(osteoporosis), 골연화증(osteomalacia), 골감소증(osteopenia), 골위축(bone atrophy), 골관절염(osteoarthritis), 치주염(periodontal disease)과 같은 골질환의 예방 또는 치료제나 기능성 식품의 첨가제로 새용될 수 있으며, 뼈의 형성 및 재생을 촉진하는 치료에 유용하게 활용될 수 있다는 이점을 가지고 있다.
PCT/KR2018/012305 2017-11-07 2018-10-18 골질환 예방 또는 치료용 약학 조성물 WO2019093673A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170147353A KR101992821B1 (ko) 2017-11-07 2017-11-07 골질환 예방 또는 치료용 약학 조성물
KR10-2017-0147353 2017-11-07

Publications (2)

Publication Number Publication Date
WO2019093673A2 WO2019093673A2 (ko) 2019-05-16
WO2019093673A3 true WO2019093673A3 (ko) 2019-06-27

Family

ID=66437768

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/012305 WO2019093673A2 (ko) 2017-11-07 2018-10-18 골질환 예방 또는 치료용 약학 조성물

Country Status (2)

Country Link
KR (1) KR101992821B1 (ko)
WO (1) WO2019093673A2 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102014200B1 (ko) 2019-07-15 2019-08-26 전남대학교산학협력단 골질환의 예방 또는 치료용 의약 조성물
KR102096793B1 (ko) 2019-07-15 2020-04-03 전남대학교 산학협력단 골질환의 예방 또는 치료용 의약 조성물
KR102466565B1 (ko) 2020-07-13 2022-11-10 전남대학교산학협력단 골질환 예방 또는 치료용 약학 조성물
KR102466564B1 (ko) 2020-07-13 2022-11-10 전남대학교산학협력단 골질환 예방 또는 치료용 약학 조성물
KR102400226B1 (ko) 2020-10-22 2022-05-20 (주)네오리젠바이오텍 골 형성 촉진용 조성물
KR20240094158A (ko) 2022-12-13 2024-06-25 전남대학교산학협력단 골질환의 예방 또는 치료용 약학 조성물
WO2024128359A1 (ko) 2022-12-16 2024-06-20 전남대학교산학협력단 골질환의 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2109447B1 (en) * 2007-01-29 2015-06-10 HanAll Biopharma Co., Ltd. N, n- dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
KR101761194B1 (ko) 2015-02-23 2017-07-25 원광대학교산학협력단 백작약 추출물을 함유하는 골대사성 질환 예방 및 치료용 조성물

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
BAK,E. ETAL: "Abstract P123: Effect of metformin on osteoclastogenesis stimulated by bone resorption inducing factors", BONE, vol. 44, June 2009 (2009-06-01), pages S300, XP026136660 *
CORTIZO, A. M.: "Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 536, no. 1-2, 24 April 2006 (2006-04-24), pages 38 - 46, XP028029545, DOI: 10.1016/j.ejphar.2006.02.030 *
EE , Y. S.: "AMP kinase acts as a negative regulator of RANKL in the lifferentiation of osteoclasts", BONE, vol. 47, no. 5, 2010, pages 926 - 937, XP027406638 *
JANG, W.G. ET AL: "Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2", BONE, vol. 48, no. 4, 2011, pages 885 - 893, XP028165837, DOI: 10.1016/j.bone.2010.12.003 *
JIANG, F.: "Experimental study on the effect of metformin on steroid - induced femoral head necrosis in mice", JOURNAL OF PRACTICAL MEDICINE, no. 20, 2014, pages 3210 - 3213 *
KANAZAWA, ETAL: "Metformin enhances the differentiation and mineralization of osteoblastic MC 3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2-expression", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 375, no. 3, 2008, pages 414 - 419, XP025398766 *

Also Published As

Publication number Publication date
WO2019093673A2 (ko) 2019-05-16
KR101992821B1 (ko) 2019-06-25
KR20190051547A (ko) 2019-05-15

Similar Documents

Publication Publication Date Title
WO2019093673A3 (ko) 골질환 예방 또는 치료용 약학 조성물
SA517381996B1 (ar) تركيبة لتضميد الجرح
SG10201907660YA (en) Use of short chain fatty acids in cancer prevention
MX367712B (es) Composiciones y metodos de inhibicion de la corrosion.
EP3572087A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF OSTEOARTHRITIS, WITH SIALYLLACTOSE OR SALT THEREOF AS THE ACTIVE SUBSTANCE
MX2021002851A (es) Reutilizacion de agente cloroso activado para el tratamiento de carne y aves.
EA201791531A1 (ru) Натуральный подсластитель
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
CA2983223A1 (en) Compositions comprising sodium chondroitin sulfate and calcium phosphateuseful as tooth remineralization agents
EP3892281A3 (en) Treatment of hepatic and/or visceral fat excess
PH12019501424A1 (en) Carboxylic acid aromatic amides as antagonists of bradykinin b1 receptor
ZA201802606B (en) Compositions for dental varnishes and methods of making and using same
WO2016115516A8 (en) Methods to prevent or treat periodontitis or peri-implantitis
MX2017014080A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
TR201908639T4 (tr) Dejeneratif göz bozukluklarının önlenmesi ve veya tedavisine yönelik safran bazlı bileşimler.
BR112016023519A2 (pt) inibidor de sinalização de wnt/ß-catenina, composição farmacêutica e método de tratamento e/ou prevenção de uma patologia definida por malformação vascular
PH12020550031A1 (en) Composition for use in the prevention and treatment of pathologies of the cardiovascular apparatus
WO2016178510A3 (ko) 진세노사이드 Ｆ1 또는 Ｒｇ3를 유효성분으로 포함하는 글리벡 내성 백혈병 예방 또는 치료용 약학 조성물
MX2015012771A (es) Procedimiento de tratamiento de la deficiencia de vitamina b12.
MX2022006903A (es) Productos orales con irritacion reducida.
MX2020008511A (es) Composicion antimicrobiana tixotropica.
EA201891592A1 (ru) Основанная на пищевых продуктах доставка терапевтического агента для лечения печеночной энцефалопатии
PH12020550222A1 (en) Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections
CA2926355C (en) Synergistic compositions with plant protection agents
TW201613861A (en) Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIIC

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18875901

Country of ref document: EP

Kind code of ref document: A2